Mulakan
BADQOMOCAWGOWLD

$ENSC entry PT 1.25-1.50 Target PTs 6-7 and higher

Panjang
Ensysce Biosciences, Inc. (NASDAQ:ENSC)  
BADQOMOCAWGOWLD  
NASDAQ:ENSC   Ensysce Biosciences, Inc.
Beyond Technical Analysis Fundamental Analysis Chart Patterns strength Supply Zone target rangezone buy buysignal buysetup waitforbreakout
3
0
beyondta fundamental chartpattern strength supplyzone target rangezone buy buysignal buysetup waitforbreakout
Ensysce Biosciences shares are trading higher after Zacks Small-Cap Research set a $23 valuation on the stock.

Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is headquartered in La Jolla, California.
Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.